Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
ACT-078573 hydrochloride
primary melanocytes but no effect on the viability in A375 cells
InChi: InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5
Chemical Name: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole
BRAF inhibitor - CAS# 918505-61-0 mostat Hydrochloride ACT-078573 hydrochlorideVemurafenib Analog is a potent BRAF inhibitor and the isomer of Vemurafenib. Vemurafenib, also known as PLX4032, RG7204 or RO5185426, is an orally bioavailable, ATP competitive, small molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib received FDA approval for the treatment of late stage melanoma on August 17, 2011. Product information CAS Number: 918505 61 0 Molecular Weight: 456. 47 Formula: C22H18F2N4O3S
US$ 112.50
US$ 160.00
US$ 150.00
US$ 170.00
US$ 2100.00
US$ 137.50